Biocon Executive Chairperson Kiran Mazumdar-Shaw said she doesn't "do a day-to-day watch" on the company's stock performance because "ours is a long-term play". "I just believe we're on the right path and we've made a huge acquisition, which may catapult us into the global league," Mazumdar-Shaw said. "I think unlocking of value is already happening," she added.